Calcium microdomains and gene expression in neurons and skeletal muscle cells

Cell Calcium ◽  
2006 ◽  
Vol 40 (5-6) ◽  
pp. 575-583 ◽  
Author(s):  
M. Angélica Carrasco ◽  
Cecilia Hidalgo
Keyword(s):  
Gene Expression ◽  
Skeletal Muscle ◽  
Muscle Cells ◽  
Skeletal Muscle Cells

scholarly journals Impact of Adenosine A2 Receptor Ligands on BCL2 Expression in Skeletal Muscle Cells

2021 ◽  
Vol 11 (5) ◽  
pp. 2272
Author(s):  
Mansour Haddad
Keyword(s):  
Gene Expression ◽  
Skeletal Muscle ◽  
Adenosine Receptors ◽  
Muscle Cells ◽  
Skeletal Muscle Cells ◽  
Qrt Pcr ◽  
A2a Receptor ◽  
Adenosine A2a ◽  
Bcl2 Expression ◽  
Bcl2 Gene

Background: Adenosine plays the role of regulating cell differentiation, proliferation, and apoptosis in various kinds of cells through the B-cell lymphoma 2 (BCL2) pathway. Objectives: Since anti-apoptotic (BCL2) expression plays a role in controlling apoptosis in some cell lines, this study was designed to investigate whether adenosine analogue, NECA (non-selective adenosine receptors agonist), selective adenosine A2B receptor antagonist, PSB 603, and a selective adenosine A2A receptor agonist, CG21680, affect BCL2-gene expression in the skeletal muscle cells of rats. The purpose of this investigation was to test the hypothesis that CG21680 treatment would significantly intensify BCL2 gene expression in rat skeletal muscle. Methods: Flasks measuring 25 cm2 were employed in culturing the rat L6 skeletal muscle cells. After treating these differential cells, the relative mRNA expression level for the BCL2 gene, at varying conditions of treatment, was measured using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Results: From the qRT-PCR analysis results, it was concluded that BCL2 expression was markedly amplified after selective adenosine A2A receptor agonist, CGS21680 (p < 0.01) treatment. More prospective validation for the adenosine receptors’ contribution in modulating apoptosis by NECA was delivered by the outcomes from the combined pre-treatment of the cells with NECA and PSB 603. These outcomes show that when starved skeletal muscle cells are treated with a combination of NECA and 100 nM PSB 603, there was a substantial decrease in comparison to either treatment used on its own. Conclusions: This study’s results showed, for the first time, an increase in BCL2 gene expression within skeletal muscle after CGS21680 treatment. Hence, the prospective escalation in BCL2 protein expression might have a protective role to play against apoptosis and avert damage to the skeletal muscle.

scholarly journals Effect of serum from sub-healthy subjects with fatigue on the gene expression profile of skeletal muscle cells

2012 ◽  
Vol 7 (2) ◽  
pp. 454-460
Author(s):  
BAO-LIANG LI ◽  
XIAO-SHAN ZHAO ◽  
XIAO-MIN SUN ◽  
JUN LI ◽  
JING CHEN ◽  
...  
Keyword(s):  
Gene Expression ◽  
Skeletal Muscle ◽  
Gene Expression Profile ◽  
Expression Profile ◽  
Healthy Subjects ◽  
Muscle Cells ◽  
Skeletal Muscle Cells

scholarly journals Induction of utrophin gene expression by heregulin in skeletal muscle cells: Role of the N-box motif and GA binding protein

1999 ◽  
Vol 96 (6) ◽  
pp. 3223-3227 ◽  
Author(s):  
A. O. Gramolini ◽  
L. M. Angus ◽  
L. Schaeffer ◽  
E. A. Burton ◽  
J. M. Tinsley ◽  
...  
Keyword(s):  
Gene Expression ◽  
Skeletal Muscle ◽  
Binding Protein ◽  
Muscle Cells ◽  
Skeletal Muscle Cells ◽  
Ga Binding Protein
Sign in / Sign up

Export Citation Format

Share Document